Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001628280-26-044713
Filing Date
2026-06-22
Accepted
2026-06-22 17:03:00
Documents
15
Period of Report
2026-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q/A cbio-20260331.htm   iXBRL 10-Q/A 60064
2 EX-31.1 cbio-10qaexhibit311peo.htm EX-31.1 4298
3 EX-31.2 cbio-10qaexhibit312pfo.htm EX-31.2 4304
  Complete submission text file 0001628280-26-044713.txt   531414

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT cbio-20260331.xsd EX-101.SCH 3765
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT cbio-20260331_def.xml EX-101.DEF 4662
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT cbio-20260331_lab.xml EX-101.LAB 133310
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT cbio-20260331_pre.xml EX-101.PRE 71242
18 EXTRACTED XBRL INSTANCE DOCUMENT cbio-20260331_htm.xml XML 13990
Mailing Address 300 FIFTH AVENUE WALTHAM MA 02451
Business Address 300 FIFTH AVENUE WALTHAM MA 02451 617-430-5595
CRESCENT BIOPHARMA, INC. (Filer) CIK: 0001253689 (see all company filings)

EIN.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 10-Q/A | Act: 34 | File No.: 001-36177 | Film No.: 261107962
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)